Radiation Oncology · 2011 · 26 citations · 23 references
PharmacyOncologyPharmacologyChemotherapyDrug DeliveryPharmacokinetics Of Anticancer AgentsCytotoxic ChemotherapyLiposomal FormulationsLiposome-based DeliveryPharmacokinetics Of Anticancer DrugsRadiation TherapyChemotherapy DeliveryChemotherapy For Prostate CancerDoxorubicin-based TherapyLiposomesMagnetic Resonance Imaging Contrast AgentsTumor Hypoxia ImagingTumor Microenvironment HypoxiaTumor Volume Measurement
BACKGROUND: Tumor vasculature frequently fails to supply sufficient levels of oxygen to tumor tissue resulting in radioresistant hypoxic tumors. To improve therapeutic outcome radiotherapy (RT) may be combined with cytotoxic agents. METHODS: In this study we have investigated the combination of RT with the cytotoxic agent doxorubicin (DXR) encapsulated in pegylated liposomes (PL-DXR). The PL-DXR formulation Caelyx was administered to male mice bearing human, androgen-sensitive CWR22 prostate carcinoma xenografts in a dose of 3.5 mg DXR/kg, in combination with RT (2 Gy/day × 5 days) performed under normoxic and hypoxic conditions. Hypoxic RT was achieved by experimentally inducing tumor hypoxia by clamping the tumor-bearing leg five minutes prior to and during RT. Treatment response evaluation consisted of tumor volume measurements and dynamic contrast-enhanced magnetic resonance imaging (DCE MRI) with subsequent pharmacokinetic analysis using the Brix model. Imaging was performed pre-treatment (baseline) and 8 days later. Further, hypoxic fractions were determined by pimonidazole immunohistochemistry of excised tumor tissue. RESULTS: As expected, the therapeutic effect of RT was significantly less effective under hypoxic than normoxic conditions. However, concomitant administration of PL-DXR significantly improved the therapeutic outcome following RT in hypoxic tumors. Further, the pharmacokinetic DCE MRI parameters and hypoxic fractions suggest PL-DXR to induce growth-inhibitory effects without interfering with tumor vascular functions. CONCLUSIONS: We found that DXR encapsulated in liposomes improved the therapeutic effect of RT under hypoxic conditions without affecting vascular functions. Thus, we propose that for cytotoxic agents affecting tumor vascular functions liposomes may be a promising drug delivery technology for use in chemoradiotherapy.
23
Pharmacokinetic Parameters in CNS Gd-DTPA Enhanced MR Imaging
Gunnar Brix, Wolfhard Semmler, Rüdiger E. Port et al. · Journal of Computer Assisted Tomography · 1991 · 665 citations
Hypoxia and Radiation Therapy: Past History, Ongoing Research, and Future Promise
Sara Rockwell, Iwona T. Dobrucki, Eugene Y. Kim et al. · Current Molecular Medicine · 2009 · 507 citations
Medicine, Cancer Biology, Oncology +16
Non-linear Least Squares Fitting in IDL with MPFIT
C. B. Markwardt · 2009 · 282 citations
Michael I. Koukourakis, Sophia Koukouraki, Alexandra Giatromanolaki et al. · Journal of Clinical Oncology · 1999 · 190 citations